Pyrimidine inhibitors of erk protein kinase and uses therof

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 239/30 (2006.01) A61K 31/505 (2006.01)

Patent

CA 2590250

Described herein are compounds that are useful as protein kinase inhibitors of formula (I); or a pharmaceutically acceptable salt thereof, wherein Ring A, Z1, Z2, U, Q, R1, R2, and L are as defined herein. These compounds, and pharmaceutically acceptable compositions thereof, are useful for treating or lessening the severity of a variety of disorders, including proliferative disorders such as cancer.

L'invention concerne des composés utilisés comme inhibiteurs de la protéine kinase, qui sont représentés par la formule (I); ou un sel pharmaceutiquement acceptable de ceux-ci. Dans cette formule, les cycles A, Z1, Z2, U, Q, R1, R2, et L sont tels que décrits dans le descriptif. Ces composés, ainsi que les compositions pharmaceutiquement acceptables de ceux-ci, sont utilisés pour traiter ou diminuer la gravité d'une variété de troubles, y compris les troubles prolifératifs tels que le cancer.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Pyrimidine inhibitors of erk protein kinase and uses therof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pyrimidine inhibitors of erk protein kinase and uses therof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrimidine inhibitors of erk protein kinase and uses therof will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1685220

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.